Cannabis trial for post-concussion problems offers hope to former NHL players


Former Vancouver Canuck Andrew Alberts says NHL alumni are hopeful a new clinical study will find cannabinoids can help treat post-concussion neurological problems.

The double-blind study will include about 100 former players from all different eras of the game — including those who played with and without helmets — and will try to determine the medicinal value of marijuana among those dealing with impairments from past concussions, including depression, post-traumatic stress disorders and progressive dementia.

The NHL Alumni Association has partnered with cannabis company Canopy Growth on the one-year study, and it will be led by NEEKA Health Canada.

Ga naar Bron